
Goldman Sachs' venture capital and private equity strategy emphasizes active, control-oriented ownership to transform acquired companies and accelerate value creation. The firm leverages its extensive global network and thematic investing approach to identify differentiated investment opportunities across various sectors and stages of the corporate lifecycle, increasingly focusing on expanding access to private markets for wealthy individuals and institutional clients.
Portfolio
88
Fund Size
$7B
Top Stage
Growth
Last 12 Mo
2
Team
Jade Mandel
Managing Director on the Goldman Sachs Growth Equity Team
Mark Midle
Managing Director
Hillel Moerman
Partner
Nishi Somaiya
Partner
Simone Verri
Partner
Xiaoyin Zhang
TMT China Head and Partner
Alexandre Flavier
Executive Director
Zartasha Chaudhry
Vice President
Anthony Arnold
Associate
Stage Distribution
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| TRM Labs | Series C | $70M | Feb 2026 |
| GridPoint | Growth | $45M | Mar 2025 |
| 73 Strings | Series B | $55M | Feb 2025 |
| Spectro Cloud | Series C | $75M | Nov 2024 |
| Go Digit | Series D | $141M | May 2024 |
| VAST Data | Series E | $118M | Dec 2023 |
| Candex | Series B | $45M | Nov 2023 |
| Rapport Therapeutics | Series B | $150M | Aug 2023 |
| Solink | Series C | $60M | Jul 2023 |
| Limble | Series B | $58M | Jun 2023 |
| Madhive | Growth | $300M | Jun 2023 |
| Digibee | Series B | $60M | Jun 2023 |
| AlphaSense | Series D | $100M | Apr 2023 |
| Bitwise Industries | Series C | $80M | Feb 2023 |
| Crux | Growth | $50M | Jan 2023 |
| Slync | Series B | $24M | Jan 2023 |
| Nested Therapeutics | Series A | $90M | Oct 2022 |
| SingleStore | Series F | $116M | Jul 2022 |
| Mayvenn | Series C | $40M | Jun 2022 |
| Omio | Series E | $80M | Jun 2022 |
| RippleMatch | Series B | $45M | Jun 2022 |
| Rimac | Growth | $536M | Jun 2022 |
| PSS Industrial Group | Series C | $55M | May 2022 |
| Data.World | Series C | $50M | Apr 2022 |
| Selina | Series B | $150M | Feb 2022 |
Top Co-Investors
Last updated: 1 March 2026